Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc **Amendment T/D 02/02/24**
-
Alluxio Founder and CEO Reveals Top Data Predictions for 2024
-
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncol
-
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
-
ICG : Notification of Major Holdings
-
Form 8.3 - Smart Metering Systems plc
-
Applied Digital Secures Additional Financing
-
Form 8.3 -GCP Asset Backed Income Fund Ltd
-
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
-
Doze Launches Luxury Duvets With Proprietary Fastener and Three-sided Zipper System
-
SONORO GOLD ANNOUNCES $1 MILLION PRIVATE PLACEMENT
-
JumpCloud Announces Micha Hershman as Chief Marketing Officer
-
Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor
-
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
-
Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germany
-
Allegro MicroSystems Introduces High-Bandwidth Current Sensor Technologies Enabling High-Performance Power Conversion
-
AGF Management Limited - Normal Course Issuer Bid
-
BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
-
Enfinite energizes three Energy Storage projects, adding 60 MW of energy to the Alberta grid
-
Komprise Elastic Replication Cuts Disaster Recovery Costs for Unstructured Data by 70%
-
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
-
Kratos Defense & Security Solutions Schedules Fourth Quarter and Fiscal Year 2023 Earnings Conference Call for Tuesday, February 13th
-
MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications
-
Jeff Ludwig Appointed to Federal Reserve Board Advisory Council
-
Accredited Solutions, Inc. Announces January Sales YOY 2024 Growth of >44% From 2023
-
Senta Brandt and Gerrick Rodrigues appointed to Global Leadership Positions at Rentschler Biopharma
-
Infinidat’s CRO Steve Sullivan Recognized as 2024 CRN® Channel Chief
-
Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
-
Constellium Provides Chanel Fragrance & Beauty Recycled Aluminium Solutions for its Collection of Mascara
-
Two Six Technologies Achieves Exceptional Strategic Growth and Record Results in 2023
-
Cybrexa Regains Rights to CBX-12
-
electroCore Expands Intellectual Property Portfolio
-
Odyssey Announces Additions to Board of Directors
-
Cancer and Blood Specialists of Georgia Opens New Oncology Clinic in Cumming
-
Avalyn to Participate in Multiple Upcoming Investor Conferences
-
Twin Disc Approves a Quarterly Cash Dividend
-
WalkMe Announces Date of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
-
Tive Reports 50% Year-Over-Year Revenue Growth in 2023
-
iCAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
-
Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines
-
Sysco to Webcast Presentation at the CAGNY 2024 Conference
-
MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications
-
Flash News: OKX Wallet Now Integrated with Dymension, a Leading Modular Blockchain Technology Provider
-
CTS Announces Fourth Quarter and Full-Year 2023 Results
-
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements
-
Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker Discovery
-
Ohmyhome Partners with SG Alliance to Extend Home-related Insurance to Homeowners and Home Buyers
-
Worksport Reports 2,050% Increase in Q4 2023 YOY Revenue, Following a 2,400% YOY Q3 Revenue Advance
-
Playtika Announces Date of Fourth Quarter 2023 Results Conference Call
-
Rodedawg Intl. Ind, Inc. (OTC: RWGI) Provides Shareholder Updates
